Can a pamphlet ease the anxiety of choosing thyroid cancer treatment?

NCT ID NCT07536412

First seen Apr 20, 2026 · Last updated Jun 20, 2026 · Updated 12 times

Summary

Low-risk thyroid cancer grows very slowly and has a 99% survival rate, but choosing among three treatment options can be stressful. This study gives patients a decision aid pamphlet right after diagnosis, before they see a surgeon. The pamphlet explains the options and lists questions to ask. Researchers will measure whether it reduces decision anxiety and helps patients feel more ready to choose.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PAPILLARY THYROID MICROCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Maryland, Baltimore

    Baltimore, Maryland, 21210, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

decision aid pamphlet (CQUPLE)

What this could lead to

If it works, this simple pamphlet could help patients feel less anxious and more ready to choose a treatment option.

What could go wrong

This is a very small early study (34 people) testing a pamphlet, not a drug. It may not reduce anxiety for everyone, and results may not apply to other cancers.

Conditions

The condition(s) this trial relates to.

papillary thyroid Microcarcinoma Thyroid Cancer, Papillary Thyroid Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.